Ovation Science Inc. Announces Private Placement
Vancouver, BC, Las Vegas, NV – September 29, 2025 (CSE: OVAT | OTCQB: OVATF) – Ovation Science Inc. (“Ovation” or the “Company”), is pleased to announce a non-brokered private placement financing of up to 4,000,000 units (each a
“Unit”) at a price of $0.05 per Unit for total proceeds of up to $200,000 (the “Offering”).
Under the Offering, each Unit will consist of one common share (a “Share”) and one share purchase warrant (a “Warrant”). Each Warrant will entitle the holder to purchase an additional Share at a price of $0.05 per share for a period of 24 months from the date of issue.
The Units issued under the Offering will be subject to a statutory hold period of four months and one day from the date of issuance.
In connection with the Offering, the Company will pay eligible finders (each a “Finder”) a fee in cash equal to 8% of the gross proceeds raised from persons introduced by the Finder and/or share purchase warrants equal to 8% of the total number of Units subscribed for by persons introduced by the Finder. The broker’s warrants will be exercisable to purchase an additional share at $0.05 per share for a period of 24 months from the date of issue.
The proceeds of the Offering will be used to advance the business of the Company and for general working capital.
About Ovation Science Inc.
Ovation Science Inc. is a research and development company that develops topical and transdermal consumer products, including its CBD/THC and other cannabinoid formulations which are licensed out and also distributed under Ovation’s own brands; ARLO CBD Beauty and InVibe® MD (“health & wellness” line); all made with its patented Invisicare® skin delivery technology. The Invisicare technology enhances the delivery of ingredients to and through the skin and is protected by patents and proprietary formulations which cannot be duplicated. With over twenty years of topical and transdermal drug delivery experience in the pharmaceutical market, Ovation’s management and science team have created a unique pipeline of over thirty proprietary medical / wellness topical and transdermal products along with a line of anti-aging / beauty formulas. Ovation earns revenues from royalties on licensees’ sales and the sale of Invisicare, along with revenue from its own product sales. Ovation has offices in Vancouver, BC Canada and Las Vegas, Nevada, USA.
Forward-Looking Statements: Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Ovation Science Inc. cautions that all forward-looking statements are inherently uncertain and that actual results may be affected by a number of material factors, many of which are beyond Ovation Science Inc.’s control.
Neither the Canadian Securities Exchange, OTC Markets nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
CORPORATE INQUIRIES:
Email: info@ovationscience.com
PH: 604-982-5700